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Persistent peripheral inflammation changes AMPA receptor (AMPAR) trafficking in
dorsal horn neurons by promoting internalization of GluR2-containing, Ca2+-impermeable
AMPARs from the synapses and by increasing insertion of GluR1-containing,
Ca2+-permeable AMPARs in extrasynaptic plasma membrane. These changes contribute
to the maintenance of persistent inflammatory pain. However, much less is known
about AMPAR trafficking during development of persistent inflammatory pain and direct
studies of extrasynaptic AMPARs functioning during this period are still lacking. Using
Complete Freund’s adjuvant (CFA)-induced model of long-lasting peripheral inflammation,
we showed that remarkable hyperalgesia and allodynia developes in 1–3 h after intraplantar
CFA injection. By utilizing patch-clamp recording combined with Ca2+ imaging, we found
a significant upregulation of extrasynaptic AMPARs in substantia gelatinosa (SG) neurons
of the rat spinal cord 2–3 h after CFA injection. This upregulation was manifested as a
robust increase in the amplitude of AMPAR-mediated currents 2–3h post-CFA. These
changes were observed specifically in SG neurons characterized by intrinsic tonic firing
properties, but not in those that exhibited strong adaptation. Our results indicate that
CFA-induced inflammation increases functional expression of extrasynaptic AMPARs in
tonically firing SG neurons during development of pain hypersensitivity and that this
increase may contribute to the development of peripheral persistent pain.
Keywords: extrasynaptic AMPA receptors, development of inflammatory pain, substantia gelatinosa neurons,
hyperalgesia, allodynia
INTRODUCTION
Persistent or chronic pain is a public health problem worldwide
andmay result from infection, inflammation, peripheral injury to
tissue or nerve. Understanding the molecular mechanisms under-
lying development and maintenance of chronic pain ensures
success of its treatment by developing alternative strategies, which
target specific molecules precisely, and would therefore be of
potential benefit in treatment or even prevention of persistent
pain. Cumulative evidence demonstrates that altered AMPAR
trafficking in dorsal horn neurons is required for the persistent
inflammatory pain maintenance. However, a role of AMPARs
in persistent inflammatory pain development is not completely
understood. Besides, current studies in this field are predomi-
nantly concentrated on synaptic AMPARs, leaving functioning of
extrasynaptic AMPARs population out of direct investigation.
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
receptors (AMPARs) expression level at extrasynaptic sites of
neuronal plasma membrane is high throughout the central
nervous system (CNS). Extrasynaptic AMPARs are localized
within spines, dendrites, and somata (Malinow and Malenka,
2002; Bredt and Nicoll, 2003). They are mobile and rapidly move
between the plasma membrane and intracellular compartments
by exocytosis and endocytosis, and can migrate laterally to and
from synaptic sites adjusting synaptic strength (Borgdorff and
Choquet, 2002; Choquet and Triller, 2003; Adesnik et al., 2005;
Cognet et al., 2006). Extrasynaptic AMPARs may also contribute
to glutamatergic signaling at nonsynaptic locations. Glutamate,
released from the presynaptic neurons and from astrocytes,
can bath the extrasynaptic plasma membrane by the glutamate
spillover and activates extrasynaptic AMPARs, thus strengthening
glutamatergic transmission. During neuropathological condi-
tions, when a primary afferent input is strong, glutamate spillover
is excessive (Allan and Rothwell, 2001) and results in increased
excitotoxic vulnerability and neurons injury (Kullmann, 2000;
Allan and Rothwell, 2001; Weng et al., 2006).
The changes in AMPAR subunit trafficking, subunit compo-
sition, phosphorylation of AMPAR subunits or their interaction
with partner proteins may contribute to spinal nociceptive trans-
mission (Santos et al., 2009; Wang et al., 2010; He et al.,
2011). In a spinal cord, AMPAR trafficking has been sug-
gested as one of key mechanisms for central sensitization, a
specific form of plasticity underlying induction and mainte-
nance of pain (Hartmann et al., 2004; Park et al., 2008, 2009;
Latremoliere and Woolf, 2009; Tao, 2010; Kopach et al., 2011).
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Recent studies demonstrated that altered AMPAR trafficking in
dorsal horn neurons is causally linked to peripheral inflamma-
tory pain maintenance (Hartmann et al., 2004; Katano et al.,
2008; Park et al., 2009). Persistent peripheral inflammation pro-
motes internalization of GluR2-containing, Ca2+-impermeable
AMPARs from the synapses (Park et al., 2009) and insertion
of GluR1-containing, Ca2+-permeable AMPARs at extrasynap-
tic membrane of lamina II dorsal horn neurons (Kopach et al.,
2011) during inflammatory pain maintenance. However, much
less is known about extrasynaptic AMPAR trafficking in dor-
sal horn neurons during development of inflammatory pain. So
far as inflammation-induced peripheral hypersensitivity devel-
ops rapidly (2–3 h) after intraplantar complete Freund’s adju-
vant (CFA) injection and is comparable to one observed during
the period of inflammatory pain maintenance (Zhang et al.,
2003; Park et al., 2009), the same peripheral inflammatory insult
may also potentially alter AMPAR trafficking in dorsal horn
neurons when hypersensitivity is being developed. The altered
AMPAR trafficking may in turn contribute to the observed
hypersensitivity and strength pain development and mainte-
nance.
In this work, we used electrophysiology combined with
[Ca2+]i imaging to study extrasynaptic AMPAR functioning in
dorsal horn substantia gelatinosa (SG) neurons during the devel-
opment period of peripheral inflammatory pain. We show that
development of inflammation-induced hyperalgesia and allody-
nia is associated with the upregulation of extrasynaptic AMPA
receptors (AMPARs) in specific subtype of lamina II dorsal horn
neuron.
MATERIALS AND METHODS
ANIMAL PREPARATION
Male rats were housed in cages on a standard 12:12 h light/dark
cycle. Water and food were available ad libitum until rats were
transported to the laboratory for experiments. The animals
were used in accordance with protocols that were approved
by the Animal Care and Use Committee at the Bogomoletz
Institute of Physiology and were consistent with the ethical guide-
lines of the National Institutes of Health and the International
Association for the Study of Pain. All efforts were made to min-
imize animal suffering and to reduce the number of animals
used.
EXPERIMENTAL DRUGS
CFA was purchased from Sigma Chemical Co. (St. Louis,
MO). Fura-2 was obtained from Invitrogen (Carlsbad, CA,
USA). Tetrodotoxin (TTX) was obtained from Alomone Labs
Ltd. (Jerusalem, Israel). NBQX, APV, AMPA, cyclothiazide
(CTZ), bicuculline, and strychnine were purchased from Tocris
Bioscience (Ellisville, MO).
INDUCTION OF PERIPHERAL INFLAMMATION
To produce unilateral peripheral inflammation and nocicep-
tive hypersensitivity, 100μl of CFA (Mycobacterium tuberculosis)
suspended in an oil-saline (1:1) emulsion was injected subcuta-
neously into the plantar side of one hind paw of the rats. Saline
injection (0.9%; 100μl) was used as a control.
BEHAVIORAL TESTING
Animals were acclimatized to the experimental setup before the
testing. The experimenters were blinded to the treatment groups
during behavioral testing.
Paw withdrawal responses to thermal stimuli were measured in
rats by using the Hargreaves technique (Hargreaves et al., 1988).
For measurement of paw withdrawal responses to noxious heat
stimuli, the animal was placed in a Plexiglas chamber on a glass
plate located above a light box (Bioseb, Italy). Radiant heat was
applied by focused infrared beam through a hole in the light
box through the glass plate to the middle of the plantar sur-
face of each hind paw. When the animal lifted its foot, the light
beam was automatically turned off. The length of time between
the start of the beam and the foot lift was defined as the paw
withdrawal latency. Each trial was repeated five times at 5-min
intervals for each paw. A cut-off time of 30 s was used to avoid
tissue damage. Behavioral tests were performed before and after
CFA injection.
To measure paw withdrawal responses to repeated mechan-
ical stimuli, we used von Frey method. A rat was placed in a
Plexiglas chamber on an elevated mesh screen and each von
Frey monofilament (Bioseb, Italy) was applied to the hind paw
for approximately 1–2 s. Trials of each hind paw were repeated
10 times at 1-min intervals. The occurrence of paw withdrawal
in each of these trials was expressed as a percentage response
frequency.
SPINAL CORD SLICE PREPARATION
Spinal cord slices were prepared from 18–21-day-old male rats
subjected to saline or CFA injection as described previously
(Voitenko et al., 2004; Kopach et al., 2011). Briefly, after rats
were deeply anesthetized with an overdose of isoflurane, the L4−5
spinal segments were removed. Transverse slices (300μm thick)
were cut on a vibratome (Campden Instrument, UK) in an ice-
cold solution that was continuously bubbledwith 95%O2 and 5%
CO2 and contained (in mM) 250 sucrose, 2 KCl, 1.2 NaH2PO4,
0.5 CaCl2, 7MgCl2, 26NaHCO3, and 11 glucose (pH 7.4). Slices
were maintained at room temperature in a physiologic Krebs
bicarbonate solution that contained (in mM) 125NaCl, 2.5 KCl,
1.25 NaH2PO4, 2 CaCl2, 1MgCl2, 26NaHCO3, and 10 glucose
(pH 7.4, osmolarity 310–320mOsM) and was equilibrated with
95% O2 and 5% CO2.
SIMULTANEOUS CA2+ IMAGING AND PATCH-CLAMP RECORDING
Simultaneous Ca2+ imaging and whole-cell electrophysiologic
recordings were obtained from SGneurons of the spinal L4−5 dor-
sal horn as described previously (Voitenko et al., 2004; Kopach
et al., 2011). Briefly, the neurons were visually identified with
a video microscope (Olympus, Japan). The patch pipettes with
resistance of 6–10M were filled with an internal solution con-
taining (in mM) 133K-gluconate, 5 NaCl, 0.5MgCl2, 10 HEPES-
Na, 2MgATP, 0.1 GTP-Na, and 0.2 fura-2 pentapotassium salt
(pH 7.2, osmolarity 290mOsM). The membrane potential of SG
neurons was held at –60mV by a patch-clamp amplifier PC-505B
(Warner Instruments, Hamden, CT) and Digidata board 1320A
(Molecular Devices, Union City, CA) controlled by pCLAMP 8.2
software (Axon Instruments, USA) in current or voltage-clamp
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mode. Only data from neurons that exhibited a resting membrane
potential negative to –60mV were included in the analysis.
Neurons were randomly chosen in the SG, but were mainly
localized in its media-lateral part (Figure 3A). All SG neurons
were categorized according to their discharge pattern in response
to the series of 1-s current pulses, as described previously (Kopach
et al., 2011).
To isolate AMPAR-mediated membrane current and associ-
ated increase in free calcium concentration in cytosol ([Ca2+]i),
we performed recordings in the continuous presence of D-APV
(50μM), bicuculline (5μM), and strychnine (2μM) to block
NMDA, GABAA, and glycine receptors, respectively. In addi-
tion, TTX (0.5μM) and cadmium chloride (100μM) were added
to Krebs bicarbonate solution to block corresponding voltage-
activated sodium and calcium channels. To prevent a desensi-
tization of AMPARs during bath application of the agonist, we
applied AMPA to the slices in the continuous presence of CTZ
(20μM). Typically, one neuron was studied per slice.
Fura-2 fluorescence from SG neurons, located between 50 and
100μm below the surface of the slice, was measured by using a
60×, NA 0.9 water-immersion objective (Olympus, Japan) and a
12-bit cooled CCD camera and capturing board (Sensicam, PCO,
Germany). Fluorescence intensity was measured at wavelengths
>510 nm when excited at 380 and 340 nm by a PolyChrome
IV monochromator (Till Photonics, Germany) using Imaging
Workbench software (INDEC System, USA). Fura-2 fluores-
cence were measured in soma and dendrites of SG neurons and
expressed as changes in the ratio of fluorescence at 340–380 nm.
The background area closest to the areas of interest was sub-
tracted for each wavelength. The amplitude of the AMPA-induced
[Ca2+]i transient was calculated as the difference between the
fura-2 fluorescence ratio before AMPA application and the ratio
at the maximum [Ca2+]i rise during AMPARs activation.
STATISTICAL ANALYSIS
All data are presented as mean ± SEM with n referring to the
number of cells analyzed. Student’s t-tests (two-tailed unpaired)
were used to determine statistically significant differences.
A p-value of less than 0.05 was considered statistically significant.
RESULTS
DEVELOPMENT OF CFA-INDUCED PERIPHERAL HYPERSENSITIVITY
Our previous studies (Park et al., 2009) and those of others
(Zhang et al., 2003; Park et al., 2008) show that subcuta-
neous injection of CFA into a hind paw led to development of
robust hypersensitivity on the ipsilateral side. This inflammation-
induced hypersensitivity reached a peak around 24 h after the
injection of CFA and maintained for a few days, representing
the maintenance period of persistent pain. Here, we examined
how persistent pain develops. For this, we thoroughly measured
paw withdrawal responses to both thermal and mechanical stim-
uli. before CFA injection, and then at 0.5, 1, 2, 3, 4, 5, 6, 7,
and 8 h after CFA injection. Consistent with previous reports
(Zhang et al., 2003), CFA injection produced a rapid develop-
ment of thermal hypersensitivity, as evidenced by a decrease in
ipsilateral paw withdrawal latency (Figure 1). This hypersensitiv-
ity was observed even at 0.5 h after CFA injection and further
progressed in following 2–4 h (n = 6; p < 0.01; Figure 1). After
4–8 h, this hypersensitivity was maintained at the similar level for
a few days after CFA injection, representing maintenance period
of CFA-induced inflammatory pain (Figure 1).
CFA (but not saline) injection led also to development of
mechanical hypersensitivity that manifested as a marked increase
in paw withdrawal frequencies in response to von Frey filaments
applied to the injected hind paw (Figure 2). As with the paw
withdrawal latency, a significant increase in paw withdrawal fre-
quency started at 0.5 h after CFA injection and further progressed
FIGURE 1 | Development of CFA-induced peripheral thermal hypersensitivity in rats. CFA injection induced a decrease in paw withdrawal latency in
response to thermal stimulation (n = 6/time point).
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FIGURE 2 | Development of mechanical hypersensitivity after CFA injection. (A,B) Paw withdrawal frequency in response to 2 g (A) and 6g (B) von Frey
filaments changed over time on the ipsilateral side after CFA, but not after saline injection into a hind paw (n > 6/time point for saline and CFA).
over 2–4 h (n = 8; p < 0.01), then was maintained for a few
days (Figure 2). In addition, CFA injection significantly increased
the paw withdrawal frequencies in response to innoxious (2
and 4 g) and noxious (6 and 8 g) von Frey filaments, indicating
development of mechanical allodynia and hyperalgesia, respec-
tively (n = 6; p < 0.01; Figures 2A,B; data for 4 and 8 g are
not shown). These results indicate that remarkable thermal and
mechanical hypersensitivities develop in a time interval of 1–6 h
after CFA injection and these changes of peripheral sensitivity
are comparable to the changes observed during the mainte-
nance period of chronic inflammatory pain (1–7 days after CFA
injection).
CFA-INDUCED INFLAMMATION UPREGULATES EXTRASYNAPTIC
AMPARs IN TONICALLY FIRING SG NEURONS RATHER THAN IN
TRANSIENT NEURONS
Previously we showed that CFA-induced peripheral inflammation
substantially increases functional expression of Ca2+-permeable
AMPARs in the extrasynaptic plasma membrane of lamina II
dorsal horn neurons during the maintenance period of persis-
tent inflammatory pain (Kopach et al., 2011) and altered AMPAR
trafficking is necessary for the maintenance of inflammatory pain
(Park et al., 2009). In this work, we studied whether CFA-induced
peripheral inflammation affects extrasynaptic AMPARs function-
ing in these neurons during the development phase of persistent
inflammatory pain. Because of our behavioral results and those
of others (Zhang et al., 2003) have shown that CFA-induced
robust thermal and mechanical hypersensitivities develop over 2–
4 h after CFA injection, we chose the time point of 3 h after CFA
injection to represent the development phase of CFA-induced
persistent inflammatory pain. To directly evaluate CFA-induced
changes in functional expression of extrasynaptic AMPARs dur-
ing inflammatory pain development, we performed simultaneous
recordings of membrane current and associated [Ca2+]i tran-
sients produced by a selective agonist of AMPARs, AMPA, 3 h
after saline or CFA injection (Figures 3A,B). We recorded AMPA-
induced [Ca2+]i transients in both the soma and dendrites of SG
neurons.
Consistent with our previous reports (Voitenko et al., 2004;
Kopach et al., 2011), bath application of AMPA (5μM, 60 s) to
the spinal cord slices evoked an inward current in all SG neurons
at a holding potential of –60mV. This current was characterized
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FIGURE 3 | AMPAR-mediated currents and associated [Ca2+]i transients
in SG neurons of spinal cord slices. (A) Transmitted light image of patch
electrode position (square) in the SG of a transverse spinal cord slice; scale
bar = 200μm. (B) A fluorescent image of SG neuron loaded with fura-2
(200μM) and current-clamp recording of typical firing pattern for tonic
neurons; scale bar = 20μm. (C) Representative trace of a membrane current
recorded from the soma in tonic neurons during AMPA bath application
(5μM) before and after pre-application of AMPAR antagonist NBQX (30μM).
(D) A statistical summary of the AMPA-induced current amplitudes (left
graph) and [Ca2+]i transients (right graph) in soma and dendrites of SG
neurons before and after pre-application of AMPAR antagonists NBQX.
∗∗p < 0.01, ∗∗∗p < 0.001 versus control.
by a slow rising phase and subsequent plateau, reached within
20–60 seconds (Figure 3C). Although bath applied AMPA acti-
vates a total pool of plasma membrane AMPARs, the extrasynap-
tic receptors are the predominant contributor to AMPA-induced
current because they are relatively more abundant in neuronal
plasma membrane and have weaker desensitization than synap-
tic AMPARs (Guire et al., 2008; Arendt et al., 2010; Vizi et al.,
2010). In addition, substantial differences in a rectification index
and a sensitivity to polyamine blockers between AMPA-induced
currents (Kopach et al., 2011) and AMPAR-mediated excitatory
postsynaptic currents evoked by dorsal root stimulation in SG
neurons (Katano et al., 2008; Vikman et al., 2008; Park et al., 2009)
further confirm a major contribution of extrasynaptic receptors
to AMPA-induced currents.
The AMPA-induced current was associated with a syn-
chronous rise in [Ca2+]i observed in both soma and dendrites
of examined neurons (Figure 3C). The observed current and
associated [Ca2+]i transients were mediated by an activation of
AMPARs, as a potent AMPAR antagonist NBQX (30μM) almost
completely inhibited both the current and [Ca2+]i transients
(Figures 3C,D). Other selective AMPAR antagonist, GYKI 52466,
also inhibited both the current and associated [Ca2+]i transients
similar to NBQX (Kopach et al., 2011), further indicating an
activation of AMPARs.
Taking into account that the population of SG neurons
is not homogeneous and displays distinct immunohistochem-
ical (Engelman et al., 1999), electrophysiological (Grudt and
Perl, 2002) and functional properties (Graham et al., 2004),
we divided all neurons accordingly to their firing pattern in a
response to sustained depolarizing current. Furthermore, our
previous results have shown that persistent peripheral inflam-
mation changes extrasynaptic AMPAR trafficking specifically in
subpopulation of SG neurons characterized by intrinsic tonic
firing properties, but not in those that exhibited strong adapta-
tion (Kopach et al., 2011). Therefore, we divided all SG neurons
tested into two main groups: “tonic” and “transient.” Tonic neu-
rons were those that supported continued discharge of action
potentials during 1-s depolarizing inward current with increased
frequency of discharge in a response to increased current inten-
sity (Figure 3B). Transient neurons were those that exhibited
a strong adaptation by generating short bursts of spikes or
just a single spike regardless of depolarizing current intensity
(Figure 5A).
In tonically firing SG neurons, the average amplitude of
AMPA-induced currents comprised 236 ± 39 pA (n = 23) in
the saline-treated group; the amplitude of associated [Ca2+]i
transients, expressed as an increase in the ratio of fura-2 fluores-
cence at 340–380 nm, R (see “Materials and Methods”), were
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0.47 ± 0.10 (n = 21) for soma and 0.60 ± 0.12 (n = 14) for den-
drites (Figures 4A,B). CFA-induced inflammation significantly
increased the amplitude of AMPA-induced current in the tonic
SG neurons 3 h after CFA injection (Figure 5C). In particular, the
average amplitude of AMPA-induced current was −236 ± 39 pA
(n = 23) in 3 h post-saline group, but −437 ± 41 pA (n = 23;
p < 0.001) in 3 h post-CFA group (Figure 4B). CFA-induced
inflammation led to a tendency toward an increase in the ampli-
tude of associated [Ca2+]i transients in soma and dendrites of
tonic SG neurons 3 h after injection (Figures 4A,B). In soma,
the average amplitudes of AMPA-induced [Ca2+]i transients were
0.47 ± 0.10 (n = 21) vs 0.54 ± 0.10 (n = 20) in the post-saline
and post-CFA groups, respectively (Figure 4B). In dendrites,
the average amplitudes of [Ca2+]i transients were 0.60 ± 0.12
(n = 14) 3 h after saline vs 0.84 ± 0.23 (n = 15) 3 h after CFA
(Figure 4B). However, these changes were not significant (p >
0.05).
These findings indicate that CFA-induced peripheral
inflammation significantly upregulates functional expression of
FIGURE 4 | Extrasynaptic AMPARs are markedly upregulated in tonic
SG neurons during development of CFA-induced inflammatory pain.
(A) Representative examples of AMPA-induced membrane current (bottom
traces) and associated [Ca2+]i transients in soma (upper black traces) and
dendrites (upper blue traces) in tonic neurons 3 h after saline (left traces) or
CFA injection (right traces). (B) A statistical summary of current amplitudes
(left graph) and [Ca2+]i transients (right graph) in soma and dendrites of
tonic SG neurons 3 h after saline or CFA injection. AMPA-induced currents
were significantly increased during chronic pain development. Despite the
tendency toward an increase in [Ca2+]i transients in SG neurons 3 h after
CFA injection, no significant change in their amplitudes was observed.
∗∗∗p < 0.001 versus the saline-treated group.
extrasynaptic AMPARs in tonically firing SG neurons during the
development period of inflammatory pain.
CFA-induced inflammation did not significantly change the
AMPA-induced current and associated [Ca2+]i transients in the
transient subtype of SG neurons during the development period
of inflammatory pain. In the saline-treated group, average ampli-
tude of AMPA-induced current was −177 ± 22 pA (n = 24) in
the transient SG neurons that was not significantly different from
that in the tonic neurons (p > 0.05). In the transient SG neurons
from the CFA-treated group, the current amplitude was −259 ±
35 pA at 3 h after CFA injection (n = 34; p > 0.05 compared to
the saline-treated group; Figures 5A–C). No significant differ-
ences were observed also in the average amplitudes of AMPA-
induced [Ca2+]i transients in soma and dendrites of transient
SG neurons between the saline- and CFA-treated groups 3 h after
injection. In soma, average amplitudes of [Ca2+]i transients were:
0.48 ± 0.09 (n = 22) and 0.39 ± 0.04 (n = 31) for the saline-
and CFA-treated groups, respectively (p > 0.05; Figure 5B). In
dendrites, average amplitudes of [Ca2+]i transients were 0.52 ±
0.09 (n = 18) for the saline-treated and 0.54 ± 0.09 (n = 18) for
the CFA-treated groups 3 h after injection (p > 0.05; Figure 5B).
These results demonstrate that in the transient type of SG neurons
extrasynaptic AMPARs functioning is not significantly altered
during development of CFA-induced inflammatory pain.
DISCUSSION
In this work, we have demonstrated that extrasynaptic AMPARs
are significantly upregulated in tonically firing dorsal horn SG
neurons during the development of persistent inflammatory pain.
This upregulation of AMPARs in dorsal horn neurons is asso-
ciated with inflammation-induced hyperalgesia and allodynia
and might contribute to the development and maintenance of
persistent inflammatory pain.
Our findings and those of others (Zhang et al., 2003; Park
et al., 2009) show that CFA-induced peripheral inflammation
produces rapid development of peripheral hyperalgesia and allo-
dynia (2–3 h after CFA injection) that represents developmental
period of persistent inflammatory pain, whereas pain hypersensi-
tivities observed during 1–7 d post-CFA reflects the maintenance
phase of inflammatory pain (Figures 1 and 2). Spinal cord dor-
sal horn sensitization is considered to be a central mechanism
that underlies the induction and maintenance of pain hypersen-
sitivities (Woolf and Salter, 2000; Latremoliere and Woolf, 2009;
Wang et al., 2010). Central sensitization produces a substantial
prolongation and enhancement of responses to both noxious and
innocuous stimuli (hyperalgesia and allodynia) and is a specific
form of synaptic plasticity in spinal cord, which depends crucially
on recruitment of glutamate receptors (Woolf and Salter, 2000;
Latremoliere and Woolf, 2009; Wang et al., 2010). Activation of
particularly NMDA receptors and AMPARs in dorsal horn neu-
rons is required for the development and maintenance of spinal
sensitization and hyperalgesia (Woolf and Salter, 2000; Hartmann
et al., 2004; Katano et al., 2008; Vikman et al., 2008; Latremoliere
and Woolf, 2009; Park et al., 2009).
Previously we and others showed that persistent inflamma-
tion produces a switch of Ca2+-impermeable to Ca2+-permeable
AMPAR-mediated neurotransmission at synapses in dorsal horn
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FIGURE 5 | ExtrasynapticAMPARsfunctioningisnotalteredinthetransient
SGneuronsduringdevelopmentofCFA-induced inflammatorypain. (A)
Typical firingpattern (left traces) and representativeexamplesofAMPA-induced
somaticcurrents (right traces) inthetransientSGneurons3 haftersaline(control)
orCFA injection. (B)Astatistical summaryof thecurrent amplitudes (left graphs)
and [Ca2+]i transients (rightgraphs) insomaanddendritesof transientSG
neurons3 hafter injectionof salineorCFA.Nosignificantdifferencewas found in
allmeasuredparameters. (C)Thescatterplot illustrates aspread in
AMPA-inducedcurrents in the tonic (blue)and transient (green) neurons3 hafter
CFA injection.Difference in theamplitudesofAMPA-inducedcurrentsbetween
the transientandtonicSGneuronswassignificant in theCFA-inflamedgroup
(p < 0.01),butnotsignificant3 hpost-saline (p > 0.05).
during the maintenance of inflammatory pain (Katano et al.,
2008; Vikman et al., 2008; Park et al., 2009) and these changes
are necessary for the peripheral inflammatory pain maintenance
(Park et al., 2009). Peripheral inflammatory insult also increases
functional expression of extrasynaptic Ca2+-permeable AMPARs
in the tonically firing SG neurons during the maintenance
period of inflammatory pain, as we reported recently (Kopach
et al., 2011). Our current work illustrates that CFA-induced
inflammation substantially upregulates extrasynaptic AMPARs
in tonically firing SG neurons during the inflammatory pain
development (3 h after CFA injection). Our electrophysiological
results suggest that the number of extrasynaptic AMPARs is sub-
stantially increased in the SG neurons during development of
CFA-induced peripheral hyperalgesia and allodynia. This upreg-
ulation of AMPARs may contribute to the observed hypersensi-
tivities during pain development, as altered AMPAR trafficking
is necessary for the persistent pain maintenance (Park et al.,
2009). In contrast to the maintenance of inflammatory pain,
AMPAR-mediated Ca2+ signaling in the tonic firing SG neu-
rons was not significantly changed during the inflammatory pain
development. We suggest that the upregulation of extrasynaptic
AMPARs during pain development may be mediated mainly by
an increase in GluR2-containing, Ca2+-impermeable AMPARs
followed by a subsequent upregulation of GluR2-lacking, Ca2+-
permeable extrasynaptic AMPARs, which was observed during
themaintenance period of persistent inflammation (Kopach et al.,
2011). Phosphorylation of AMPAR subunits may underlie the
observed CFA-induced upregulation of extrasynaptic AMPARs
in dorsal horn SG neurons during inflammatory pain develop-
ment. As we have demonstrated previously, CFA injection signif-
icantly changes the level of GluR2 phosphorylation 2 h after CFA
injection (Park et al., 2009), supporting our current electrophys-
iological results. However, the precise mechanisms of AMPARs
regulation are not completely clear because of their complexity
(Santos et al., 2009; Wang et al., 2010; He et al., 2011).
Other important finding of this study is the fact that
extrasynaptic AMPAR upregulation during development of per-
sistent inflammatory pain was observed specifically in a subpopu-
lation of SG neurons that exhibit intrinsic tonic firing properties,
with no significant changes in the neurons that exhibit strong
adaptation (transient neurons). This indicates that CFA alters
extrasynaptic AMPARs in tonic firing SG neurons, whereas the
pool of extrasynaptic AMPAR in the transient neurons is stable
during the development of inflammatory pain and even during
the persistent painmaintenance (Kopach et al., 2011). Taking into
account similar patterns of extrasynaptic AMPAR expression in
tonic and transient SG neurons under normal conditions (Kopach
et al., 2011), these findings suggest different contribution of
neuronal subtypes to the detection and/or transmission of noci-
ceptive stimuli, resulting in different involvement in persistent
inflammatory pain development and maintenance.
In conclusion, our study shows that CFA-induced periph-
eral inflammation upregulates extrasynaptic AMPARs specifi-
cally in tonic firing SG neurons during the development of
inflammatory pain. These neurons may represent a specific
population of neurons that carry out nociceptive inputs and
www.frontiersin.org October 2012 | Volume 3 | Article 391 | 7
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contribute to spinal central sensitization during development and
maintenance of persistent inflammatory pain. The upregulated
extrasynaptic AMPARs in dorsal horn neurons during the inflam-
matory pain development might contribute to persistent pain
hypersensitivities.
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